Skip to content

Optimized Strict Fluid Management Helps Improve Endpoints After Liver Dissection

The Effect of Different Fluid Therapy on Major Postoperative Morbidity in Patients Undergoing Non-donor Hepatectomy: a Pilot Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07440121
Acronym
SHIELD-pilot
Enrollment
90
Registered
2026-02-27
Start date
2026-04-02
Completion date
2027-02-02
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Surgery

Keywords

fluid therapy, hepatectomy, acute kidney injury

Brief summary

During hepatectomy, surgeons often prefer to restrict fluid intake, believing that this can lower central venous pressure (CVP) and reduce intraoperative blood loss. However, fluid restriction may lead to inadequate perfusion of vital organs and even contribute to postoperative organ dysfunction, such as acute kidney injury (AKI). Therefore, this study aims to compare the effects of restrictive versus liberal fluid therapy on major complications following hepatectomy.

Interventions

OTHERrestrictive fluid infusion

Fluid infusion is restricted at 2 ml·kg- 1·h- 1 from the moment the patient arrive in the operating room to immediately after the liver lesions are removed

OTHERpreload

6 ml·kg- 1·h- 1 of hydroxyethyl starch solution is infused before anesthesia

OTHERnitro

Nitroglycerin is infused from start of anesthesia to immediately after the liver lesions are removed.The starting infusion rates of nitroglycerin is 0.5 μg·kg- 1·min- 1 . If the speed of administration requires adjustment, nitroglycerin is added or decreased by 0.1 μg·kg- 1·min- 1.

Sponsors

Zhihong LU
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* scheduled for elective hepatectomy under general anesthesia * age ≥18 yrs old

Exclusion criteria

* American society of anesthesiologists status over 3 * existed kidney disease or renal dysfunction * severe cardiac or respiratory dysfunction * neurological or psychiatric disease * Child-Pugh class C (score 10-15)

Design outcomes

Primary

MeasureTime frameDescription
incidence of acute kidney injuryfrom end of surgery to 7 days after surgeryPostoperative acute kidney injury (AKI) was diagnosed and staged according to the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Acute Kidney Injury (2012). AKI was defined as the presence of any of the following criteria within 7 days after surgery: an increase in serum creatinine by ≥ 0.3 mg/dL (≥ 26.5 μmol/L) within 48 hours; an increase in serum creatinine to ≥ 1.5 times baseline, which is known or presumed to have occurred within the prior 7 days; or urine volume \< 0.5 mL/kg/h for 6 consecutive hours. Baseline serum creatinine was defined as the most recent preoperative value available within 3 months prior to surgery.

Secondary

MeasureTime frameDescription
Severity of acute kidney injuryfrom end of surgery to discharge from hospital, at an average of 7 daysAKI severity was further classified into three stages: stage 1 was defined as serum creatinine 1.5-1.9 times baseline or an increase of ≥ 0.3 mg/dL (≥ 26.5 μmol/L), or urine output \< 0.5 mL/kg/h for 6-12 hours; stage 2 as serum creatinine 2.0-2.9 times baseline, or urine output \< 0.5 mL/kg/h for ≥ 12 hours; and stage 3 as serum creatinine 3.0 times baseline, or an increase in serum creatinine to ≥ 4.0 mg/dL (≥ 353.6 μmol/L), or initiation of renal replacement therapy, or urine output \< 0.3 mL/kg/h for ≥ 24 hours, or anuria for ≥ 12 hours
number of patients with post-hepatectomy liver failurefrom end of surgery to discharge from hospital, at an average of 7 days
number of patients with major cardiac complicationsfrom end of surgery to discharge from hospital, at an average of 7 daysheart failure, myocardial ischemia and new on-set arrythmia
volume of blood lossfrom start of surgery to end of surgery, at an average of 3 hoursThe method for calculating blood loss is the volume in the suction canister plus the estimated amount of blood on the gauze
numerical rating scale of surgeon's satisfaction to the surgical fieldat the end of the surgery0 is extremely unsatisfied, 10 is extremely satisfied
control of central venous pressure during resectionfrom start of resection to end of removal of the liver lesions ,at an average of 2 hours0, uncontrolled central venous pressure (CVP), defined as the target CVP of \< 5 cmH₂O was achieved for at least 75% of the resection period; 1, defined as the target CVP of \< 5 cmH₂O was achieved for 50% -75% of the resection period; 1, defined as the target CVP of \< 5 cmH₂O was achieved for less than 50% of the resection period
dose of norepinephrinefrom start of surgery to end of surgery, at an average of 3 hours
frequency of hypotensionfrom start of surgery to end of surgery, at an average of 3 hourshypotension is defined as mean arterial pressure less than 60 mmHg
arterial lactate levelupon completion of surgery,that is, end of incision suture,at an average of 3 hours after anesthesia induction
surgical field bleeding scoreat the end of the surgery, ,at an average of 3 hours after anesthesia induction0=no bleeding; 1=minor bleeding, no aspiration required; 2=minor bleeding, aspiration required; 3 = minor bleeding, frequent aspiration required ; 4 = moderate bleeding, visible only aspiration; 5 = severe bleeding, frequent aspiration required, very hard to perform surgery

Contacts

CONTACTZhihong Lu
deerlu23@163.com86-13891975018

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026